Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.35USD
20 Apr 2018
Change (% chg)

$-0.10 (-4.08%)
Prev Close
$2.45
Open
$2.40
Day's High
$2.40
Day's Low
$2.35
Volume
14,322
Avg. Vol
53,077
52-wk High
$5.75
52-wk Low
$1.58

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.24 December 21 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 1.38 2.20 0.65 2.00
Quarter Ending Sep-18 3 3.65 7.90 0.55 26.00
Year Ending Dec-18 4 7.88 11.30 2.40 29.53
Year Ending Dec-19 4 21.33 30.10 9.10 73.69
Earnings (per share)
Quarter Ending Jun-18 4 -0.24 -0.19 -0.33 -0.27
Quarter Ending Sep-18 4 -0.22 -0.20 -0.24 0.08
Year Ending Dec-18 4 -1.00 -0.85 -1.14 -0.71
Year Ending Dec-19 4 -0.90 -0.70 -1.06 -0.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 5.25 0.74 4.51 85.90
Quarter Ending Sep-17 2.22 1.49 0.73 32.88
Quarter Ending Jun-17 2.27 2.66 0.39 17.28
Quarter Ending Mar-17 1.80 3.11 1.30 72.32
Quarter Ending Dec-16 3.71 6.43 2.73 73.53
Earnings (per share)
Quarter Ending Dec-17 -0.20 -0.20 0.00 -1.68
Quarter Ending Sep-17 -0.27 -0.28 0.01 -4.36
Quarter Ending Jun-17 -0.28 -0.29 0.01 -2.95
Quarter Ending Mar-17 -0.27 -0.34 0.07 -26.72
Quarter Ending Dec-16 -0.23 -0.21 0.03 -10.64

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1.38 1.38 1.38 1.30 2.00
Quarter Ending Sep-18 3.65 3.65 3.65 7.90 26.00
Year Ending Dec-18 7.88 7.88 7.73 16.73 29.53
Year Ending Dec-19 21.33 21.33 21.33 12.40 73.69
Earnings (per share)
Quarter Ending Jun-18 -0.24 -0.24 -0.24 -0.22 -0.27
Quarter Ending Sep-18 -0.22 -0.22 -0.20 -0.24 0.08
Year Ending Dec-18 -1.00 -1.00 -1.00 -1.01 -0.71
Year Ending Dec-19 -0.90 -0.90 -0.88 -0.93 -0.03

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 1
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 0 1